-
Crowdfunding for Cancer
Researchers found that millions of dollars are donated on fundraising sites to support ineffective and even harmful treatments.
by Jon Kelvey
-
An Uncommon Partnership
Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
-
October 19: The Week in Cancer News
A study investigates cancer care for rural children, and the U.S. Food and Drug Administration approves a new breast cancer therapy.
by Kate Yandell
-
October 12: The Week in Cancer News
A study sheds light on the difficulty patients have in accessing their medical records, and the U.S. Food and Drug Administration expands approval of the human papillomavirus vaccine.
by Kate Yandell
-
October 5: The Week in Cancer News
Cancer immunology researchers are awarded a Nobel Prize, and a seventh immune checkpoint inhibitor is approved by the U.S. Food and Drug Administration.
by Kate Yandell
-
Why I Put Down My Camera
A professional photographer shares advice on living in the moment after caring for his father, who had stage IV lung cancer.
by Jay Perry
-
Vaccinating Against Cancer
The human papillomavirus vaccine can significantly cut recipients' risk of several types of cancer. So why are vaccination rates relatively low in the U.S.?
by Brad Jones
-
September 28: The Week in Cancer News
A study characterizes “chemo brain” in breast cancer patients treated with chemotherapy, and physicians and scientists gather in Toronto to present their lung cancer research.
by Kate Yandell
-
Sacrificing for Care
A study finds that patients with cancer not only say they are willing to make financial sacrifices for treatment but actually have done so.
by Marilyn Fenichel
-
The Genetics of Metastatic Cancer
The multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.
by Anna Azvolinsky
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff